Ercem Atillasoy M.D.
Net Worth
Last updated:
What is Ercem Atillasoy M.D. net worth?
The estimated net worth of Dr. Ercem Atillasoy M.D. is at least $4,529,473 as of 20 Oct 2022. He owns shares worth $1,550,452 as insider, has earned $116,721 from insider trading and has received compensation worth at least $2,862,300 in AlloVir, Inc..
What is the salary of Ercem Atillasoy M.D.?
Dr. Ercem Atillasoy M.D. salary is $572,460 per year as Chief Regulatory & Safety Officer in AlloVir, Inc..
How old is Ercem Atillasoy M.D.?
Dr. Ercem Atillasoy M.D. is 61 years old, born in 1964.
What stocks does Ercem Atillasoy M.D. currently own?
As insider, Dr. Ercem Atillasoy M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| AlloVir, Inc. (ALVR) | Chief Regulatory & Safety Officer | 131,372 | $11.8 | $1,550,452 |
What does AlloVir, Inc. do?
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts.
Ercem Atillasoy M.D. insider trading
AlloVir, Inc.
Dr. Ercem Atillasoy M.D. has made 8 insider trades between 2020-2022, according to the Form 4 filled with the SEC. Most recently he sold 1,527 units of ALVR stock worth $12,955 on 20 Oct 2022.
The largest trade he's ever made was exercising 4,639 units of ALVR stock on 25 Jan 2022. As of 20 Oct 2022 he still owns at least 131,372 units of ALVR stock.
AlloVir key executives
AlloVir, Inc. executives and other stock owners filed with the SEC:
- Dr. Diana M. Brainard M.D. (54) Chief Executive Officer & Director
- Dr. Ercem Atillasoy M.D. (61) Chief Regulatory & Safety Officer
- Mr. David L. Hallal (59) Executive Chairman
- Mr. Vikas Sinha C.A., CPA, M.B.A. (62) Pres, Chief Financial Officer & Director